Sanofi

Allergan, Genzyme, Biogen move on M&A speculation
Marketwatch
Fri, 07/2/10 - 10:11 am
M&A
Biogen Idec
Allergan
Genzyme
Sanofi
Five Key Factors Weighing on Dendreon
Seeking Alpha
Fri, 07/2/10 - 08:17 am
Dendreon
Provenge
prostage cancer
Eli Lilly
JNJ
Sanofi
Sanofi Reportedly Sizing Up Big U.S. Deal
TheStreet.com
Fri, 07/2/10 - 08:16 am
M&A
Sanofi
US FDA probes possible risks of Lilly drug, others
Reuters
Thu, 07/1/10 - 09:06 am
FDA
Eli Lilly
Effient
Multaq
Sanofi
Backgrounders On Today's Biotech Deals
Forbes
Wed, 06/30/10 - 09:47 am
TargeGen
Sanofi
Celgene
M&A
companies
Sanofi-Aventis to buy U.S.-based TargeGen
Marketwatch
Wed, 06/30/10 - 08:41 am
M&A
Sanofi
TargeGen
Drug Companies' Investment Appeal
Smart Money
Wed, 06/30/10 - 08:39 am
Pfizer
Merck
Eli Lilly
Bristol-Myers Squibb
Novartis
Roche
AstraZeneca
GSK
Sanofi
Eli Lilly: This Big Pharma Needs to Get Better
Seeking Alpha
Tue, 06/29/10 - 08:51 am
Eli Lilly
Pfizer
Sanofi
Bristol-Myers Squibb
Humalog
Zyprexa
Cymbalta
patents
Gemzar
Wonder Drugs
Barron's
Sat, 06/26/10 - 11:15 am
Pfizer
Merck
AstraZeneca
GSK
BMS
Novartis
Sanofi
Eli Lilly
Roche’s Taspoglutide Works Better Than Lantus, Byetta in Trials
BusinessWeek
Sat, 06/26/10 - 10:29 am
Roche
taspoglutide
Sanofi
Eli Lilly
Amylin
Byetta
Merck
Januvia
diabetes
Improved Outcomes for Patients Treated with Lantus® and Apidra® Regimen Compared with Sliding Scale Insulin
Yahoo/BusinessWire
Sat, 06/26/10 - 09:31 am
Lantus
Apidra
Sanofi
diabetes
ImmunoGen gets $1 million from partner
Yahoo/AP
Fri, 06/25/10 - 12:25 pm
Immunogen
cancer
partnerships
Sanofi
Sanofi-Aventis signs license deal with Metabolex
Marketwatch
Fri, 06/25/10 - 10:13 am
Sanofi
licensing
Metabolex
diabetes
Sanofi-Aventis Is `on Track' to Meet Diabetes Sales Targets, Chancel Says
Bloomberg
Thu, 06/24/10 - 08:41 am
Sanofi
diabetes
Lantus
Victoza
Novo Nordisk
Sanofi May Pay Regulus Up to $750 Million in Deal
Bloomberg
Tue, 06/22/10 - 09:00 am
Sanofi
Regulus
drug development
Isis Pharmaceuticals
Alnylam
fibrosis
Double the Approvals! Double the Fun!
Motley Fool
Sat, 06/19/10 - 12:52 pm
Sanofi
Novartis
Dendreon
JNJ
Medivation
Bristol-Myers Squibb
Merck
Sanofi Drops Most in Month on Concern Diabetes Drug May Raise Cancer Risk
Bloomberg
Fri, 06/18/10 - 09:28 am
Lantus
diabetes
Sanofi
FDA approves Sanofi-Aventis prostate cancer drug
Yahoo/AP
Fri, 06/18/10 - 07:39 am
FDA
prostate cancer
Sanofi
Jevtana
Sanofi Keeps July 4 Traditions Alive With Layoff Rumors and Promises of Cuts to Come
BNET Pharma
Thu, 06/17/10 - 06:56 pm
layoffs
cafepharma
Sanofi
Sanofi to Further Cut Costs, Reduce Sales Force, Contamine Says
Bloomberg
Wed, 06/16/10 - 08:18 am
Sanofi
layoffs

Pages